02:07
Critical Quality Attributes (CQA): The importance in analytical data
01:16
Research-grade molecules: Why are they available?
01:44
Drawbacks with research-grade molecules
01:22
The 3 main reasons to use research-grade molecules
01:34
Clinical-grade reference drugs as a basis for characterization during early drug development
01:44
Similar but different: clinical-grade vs. research-grade molecules
09:29
Ashley Reid - Winner of Evidentic's Scholarship
02:24
What are the use cases for drug aliquots?
02:18
What do I get from Evidentic?
01:37
Why different Batches?
02:04
What can Evidentic do for me?
01:58
Why did you found Evidentic?
X
About
Evidentic is the first provider to offer clinical-grade molecules from original EU-licensed drugs as research consumables. Evidentic thus solves a central problem of the biosimilar manufacturers: to source different batches of biotechnologically manufactured drugs usually not available on the market at the same time. For researchers in industry and universities, our business model allows buying therapeutic molecules as consumables instead of buying expensive original vials, sharing aliquots between research groups or using alternative antibodies.
Tags